Welcome to our dedicated page for Ellomay Cap SEC filings (Ticker: ELLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ellomay Capital Ltd. filings document a foreign private issuer focused on renewable energy and power generation and development in Europe, the United States and Israel. Its Form 20-F and Form 6-K reports disclose operating and financial results, project development costs, portfolio holdings, and securities listed on the NYSE American and the Tel Aviv Stock Exchange.
The company’s regulatory record also covers material-event disclosures tied to asset sales, Ellomay Luzon Energy Infrastructures Ltd., Dorad Energy Ltd., and capital-structure matters involving Series E Secured Debentures, collateral and repayment notices. Governance filings include principal shareholder changes, board composition updates, registration-statement incorporation by reference, and risk-related forward-looking statement disclosures.
Ellomay Capital Ltd. entered a binding separation agreement to sell its indirect stake in Dorad Energy through Ellomay Luzon Energy. The deal values Dorad at NIS 4.4 billion, implying consideration of approximately NIS 560 million for Ellomay’s indirect holding and related assets.
Ellomay Clean Energy LP and the Luzon Group signed a share purchase agreement on March 27, 2026. Closing is subject to approvals from the Israeli Electricity Authority, Israeli Competition Authority and Ellomay Luzon Energy’s lenders. Each side deposited NIS 72 million in escrow, with liquidated damages and alternative valuation mechanics if one party breaches or if the transaction is not completed within seven and a half months.
The company states the transaction is expected to deliver a substantial profit, support its financial position and align with its long-term growth and portfolio management strategy.
Ellomay Capital Ltd. is updating investors on proposed amendments to its Israeli debentures following a change in control. The company has asked the trustee to convene meetings for each of its Series D, E, F and G debentures, with agendas that include approval of the change of control and related amendments to the deeds of trust.
For Series D Convertible Debentures, Ellomay intends to seek approval to reduce the conversion price from NIS 165 per ordinary share to NIS 101.5 per ordinary share. This reduction requires court approval, any additional approvals the court may require (potentially including debenture holder and shareholder approvals), and listing approvals from the NYSE American and the Tel Aviv Stock Exchange. The company states that it cannot currently estimate whether or when this change will be implemented and notes that there is no assurance that the change of control or any of the proposed amendments will be approved.
Ellomay Capital Ltd. director and Chief Executive Officer Fridrich Ran P. filed an initial Form 3, which is a statement of beneficial ownership as an insider. The filing does not report any share purchases, sales, exercises, gifts, or other transactions.
Ellomay Capital Ltd. director Sheizaf Ben submitted an initial insider ownership report on Form 3. This filing establishes his status as a director and provides a baseline record of any equity interests he may hold in the company, without reporting any recent share purchases or sales.
Ellomay Capital Ltd. director Daniel Vaknin has filed an initial Form 3 reporting his stock option holdings. He holds six option grants over Ordinary Shares, with exercise prices of $34.30, $28.50, $27.22, $16.11, $12.02, and $18.05, expiring between 2030 and 2035, covering blocks of 583 or 1,000 underlying shares each.
This Form 3 identifies Shaltiel Maya, the Chief Strategy Officer of Ellomay Capital Ltd., as a reporting person. The provided data shows no reported transactions, no derivative positions, and no share holdings, indicating a baseline insider ownership filing without trading activity.
Ellomay Capital Ltd. Chief Financial Officer Rubenbach Kalia filed an initial ownership report showing holdings of stock options over Ordinary Shares. The filing lists two option grants covering a combined 73,500 underlying Ordinary Shares at exercise prices of 29.3600 and 27.1400 per share.
One grant for 9,000 underlying shares, granted on November 30, 2021, is fully vested and expires on November 30, 2031. A second grant for 64,500 underlying shares, granted on January 12, 2026, will vest in three tranches through January 12, 2029 and expires on January 11, 2036.
Ellomay Capital Ltd. director Ohayon Odelya reported existing derivative holdings in a Form 3. The filing shows a stock option to buy 417 underlying ordinary shares at an exercise price of 25.0000 per share, exercisable from 2027-03-04 and expiring on 2036-03-04, held as a direct ownership position.
Ellomay Capital Ltd. director Dorit Ben Simon filed an initial ownership report showing holdings of stock options over Ordinary Shares. The filing lists three option grants covering 616, 1,000 and 1,000 underlying shares at exercise prices of 15.1900, 12.0200 and 18.0500, expiring between 2033 and 2035. These entries reflect existing option positions rather than new share purchases or sales.